On behalf of the chairs of the symposium Dr Chih-Tsung Yang and Dr Michelle Maritz and myself, I thank all the speakers of the inaugural ‘International Symposium: Bioengineered Cancer Models’. What a great turn out for what ended being a very exciting event with fascinating presentations illustrating the potential of bioengineered models in immunotherapy and radiotherapy.


‘International Symposium: Bioengineered Cancer Models’

9:30 – 10:00 Guest arrival and coffee
10:00 – 10:15


Chair: Professor Peter Hoffmann

Opening session

Acknowledgement of Country and Introduction of SA Chief Scientist: Professor Peter Hoffmann (University of South Australia)

Opening note: Professor Caroline McMillen (SA Chief Scientist)

Introduction of French – South Australia collaboration: Ms Patricia Thomasi (A/Director, Office of the French Strategy, Department of the Premier and Cabinet)

10:15 – 12:00


Chair: Professor Benjamin Thierry

Session 1

10:15: Adapting a 3D Microfluidic Culture System to Study Immune Checkpoint Blockade for Personalized Immunotherapy Developing a Functional Precision Medicine Platform for Immuno-Oncology Dr Amir Aref (Dana Farber Cancer Research Institute, Harvard University)

10:50: Professor Wayne Tilley (University of Adelaide)

11:25: A new versatile microfluidic system to simulate human physiology in a chip Dr Pierre Gaudriault (Cherry Biotech)

12:00 – 13:00 Lunch
13:00 – 14:45


Chair: Dr Chih-Tsung Yang

Session 2

13:00: 3D vascularised microfluidic systems to study the role of tumour stromal cells in immunotherapy of triple negative breast cancer A/Professor Majid Ebrahimi Warkiani (University of Technology Sydney)

13:35: 3D bioprinting of high-throughput (HTP) tumour spheroids for precision medicine Dr Lakmali Atapattu (University of New South Wales)

14:10: Development of a novel solid tumour CAR-T therapy Dr Justin Coombs (Carina Biotech)

15:05 – 16:30



Chair: A/Professor Ivan Kempson




Session 3

15:05: Proton Therapy – Coming Soon to Australia Associate Professor Hien Le (Radiation Oncology, Royal Adelaide Hospital)

15:15: Radiation biology and the quest for personalized cancer therapies: in vitro and in silico approaches Professor Eva Bezak (University of South Australia)

15:50: Towards bioengineered head and neck cancer models Dr Michelle Maritz (University of South Australia)

16:15: Quantitative Imaging and Machine Learning in Translational Research Dr Jonathan Cechetto (PerkinElmer)

16:30 -16:50




Chair: Professor Benjamin Thierry

Selected flash presentation session

16:30: Decoding the endosomal trafficking system through live-cell microscopy Dr. Senthil Arumugam (University of New South Wales)

16:35: Pre-clinical assessment of Chimeric Antigen Receptor (CAR)T cells using patient derived xenograft (PDX) mouse models Dr. Alla Dolnikov (Kids Cancer Centre, Sydney Children’s Hospital)

16:40: A humanised bone marrow xenotransplantation model of Acute Myeloid Leukaemia to predict patient outcome and direct therapy Dr Thao M. Nguyen (University of South Australia)

16:45: Drop-on-demand 3D bioprinting of 3D cell models Dr Robert Utama (Inventia Life Science)

‘International Symposium: Bioengineered Cancer Models’